• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏血小板生成素受体c-Mpl的小鼠中的造血干细胞缺陷。

Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin.

作者信息

Kimura S, Roberts A W, Metcalf D, Alexander W S

机构信息

The Walter and Eliza Hall Institute for Medical Research and The Cooperative Research Centre for Cellular Growth Factors. PO Royal Melbourne Hospital, Victoria 3050, Australia.

出版信息

Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1195-200. doi: 10.1073/pnas.95.3.1195.

DOI:10.1073/pnas.95.3.1195
PMID:9448308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC18717/
Abstract

Thrombopoietin (TPO) acts as a lineage-specific late-acting factor to stimulate megakaryocyte and platelet formation. However, analysis of mice lacking either the cytokine or its receptor, c-Mpl, also revealed deficiencies in progenitor cells of multiple hematopoietic lineages, suggesting that TPO signaling may play an important role in the regulation of the hematopoietic stem cell compartment. To investigate this hypothesis, we determined preprogenitor and colony forming unit-spleen (CFU-S) numbers and analyzed the long-term hematopoietic repopulating capacity of bone marrow cells from mpl-/- mice. mpl-/- mice had 4- to 12-fold fewer preprogenitor cells than wild-type mice. In irradiated normal recipients, mpl-/- bone marrow generated 8- to 10-fold fewer spleen colonies than wild-type marrow at both 8 and 12 days after transplantation. This defect was intrinsic to the transplanted hematopoietic cells, as the microenvironment of mpl-/- recipients supported similar CFU-S growth to that observed in wild-type recipients. In definitive assays of stem cell function, bone marrow cells from mpl-/- mice failed to compete effectively with normal cells for long-term reconstitution of the hematopoietic organs of irradiated recipients, even when transplanted in 10-fold excess. Serial transplantation studies further suggested that stem cell self-renewal also may be compromised in mpl-/- mice. These data imply that TPO, signaling through c-Mpl, plays a vital physiological role in the regulation of hematopoietic stem cell production and function.

摘要

血小板生成素(TPO)作为一种谱系特异性晚期作用因子,可刺激巨核细胞和血小板的形成。然而,对缺乏该细胞因子或其受体c-Mpl的小鼠进行分析后发现,多种造血谱系的祖细胞也存在缺陷,这表明TPO信号传导可能在造血干细胞区室的调节中发挥重要作用。为了验证这一假设,我们测定了前祖细胞和脾集落形成单位(CFU-S)的数量,并分析了mpl-/-小鼠骨髓细胞的长期造血重建能力。mpl-/-小鼠的前祖细胞数量比野生型小鼠少4至12倍。在接受辐照的正常受体中,移植后8天和12天,mpl-/-骨髓产生的脾集落比野生型骨髓少8至10倍。这种缺陷是移植的造血细胞所固有的,因为mpl-/-受体的微环境支持与野生型受体相似的CFU-S生长。在干细胞功能的确定性检测中,即使以10倍的过量移植,mpl-/-小鼠的骨髓细胞也无法与正常细胞有效竞争,以长期重建辐照受体的造血器官。连续移植研究进一步表明,mpl-/-小鼠的干细胞自我更新能力也可能受损。这些数据表明,通过c-Mpl传导信号的TPO在造血干细胞的产生和功能调节中起着至关重要的生理作用。

相似文献

1
Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin.缺乏血小板生成素受体c-Mpl的小鼠中的造血干细胞缺陷。
Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1195-200. doi: 10.1073/pnas.95.3.1195.
2
Thrombopoietin signaling is required for in vivo expansion of IL-11--responsive hematopoietic progenitor cells in the steady state.在稳态下,血小板生成素信号传导是白细胞介素-11反应性造血祖细胞体内扩增所必需的。
Exp Hematol. 2001 Feb;29(2):138-45. doi: 10.1016/s0301-472x(00)00622-6.
3
Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.血小板生成素不会诱导表达Mpl-R的多能祖细胞发生谱系限制的定向分化,但能使其完全向红系和巨核系分化。
Blood. 1997 May 15;89(10):3544-53.
4
Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl.缺乏血小板生成受体c-Mpl的小鼠中多种造血谱系祖细胞的缺陷及巨核细胞生成缺陷。
Blood. 1996 Mar 15;87(6):2162-70.
5
The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor.c-mpl基因缺陷小鼠中的残余巨核细胞和血小板生成并不依赖于白细胞介素-6、白细胞介素-11或白血病抑制因子的作用。
Blood. 2000 Jan 15;95(2):528-34.
6
Hematopoietic deficiencies in c-mpl and TPO knockout mice.c-mpl和血小板生成素基因敲除小鼠的造血缺陷
Stem Cells. 1998;16(1):1-6. doi: 10.1002/stem.160001.
7
Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit.血小板生成素可独立于通过gp130受体亚基发出信号的细胞因子,刺激巨核细胞集落形成单位增殖和巨核细胞成熟。
Blood. 1996 Sep 15;88(6):2026-32.
8
Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice.血小板生成素和c-mpl基因缺陷小鼠中红系和髓系祖细胞水平较低。
Blood. 1996 Aug 1;88(3):803-8.
9
Role of c-mpl in early hematopoiesis.c-mpl在早期造血过程中的作用。
Blood. 1998 Jul 1;92(1):4-10.
10
Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness.血小板生成素反应性丧失并不能完全解释STAT5缺陷型骨髓的造血重建缺陷。
Blood. 2004 Apr 15;103(8):2965-72. doi: 10.1182/blood-2003-08-2963. Epub 2003 Dec 30.

引用本文的文献

1
Autophagosome-lysosome mediated secretion of the thrombopoietin receptor is modulated by distinct driver mutations of myeloproliferative neoplasm.自噬体-溶酶体介导的血小板生成素受体分泌受骨髓增殖性肿瘤不同驱动突变的调节。
Leukemia. 2025 Jul 3. doi: 10.1038/s41375-025-02676-6.
2
TET2 deficiency increases the competitive advantage of hematopoietic stem and progenitor cells through upregulation of thrombopoietin receptor signaling.TET2缺陷通过上调血小板生成素受体信号增强造血干细胞和祖细胞的竞争优势。
Nat Commun. 2025 Mar 10;16(1):2384. doi: 10.1038/s41467-025-57614-y.
3
Cullin-5 controls the number of megakaryocyte-committed stem cells to prevent thrombocytosis in mice.Cullin-5控制巨核细胞定向干细胞的数量以防止小鼠血小板增多。
Blood. 2025 Mar 6;145(10):1034-1046. doi: 10.1182/blood.2024025406.
4
G2 arrest primes hematopoietic stem cells for megakaryopoiesis.G2 期阻滞促进造血干细胞向巨核细胞分化。
Cell Rep. 2024 Jul 23;43(7):114388. doi: 10.1016/j.celrep.2024.114388. Epub 2024 Jun 26.
5
Understanding megakaryocyte phenotypes and the impact on platelet biogenesis.了解巨核细胞表型及其对血小板生成的影响。
Transfusion. 2024 Jul;64(7):1372-1380. doi: 10.1111/trf.17927. Epub 2024 Jun 26.
6
Megakaryocytic IGF1 coordinates activation and ferroptosis to safeguard hematopoietic stem cell regeneration after radiation injury.巨核细胞 IGF1 通过协调激活和铁死亡来保障辐射损伤后造血干细胞的再生。
Cell Commun Signal. 2024 May 27;22(1):292. doi: 10.1186/s12964-024-01651-5.
7
Differential in vivo roles of Mpl cytoplasmic tyrosine residues in murine hematopoiesis and myeloproliferative disease.Mpl 细胞质酪氨酸残基在体内对小鼠造血和骨髓增生性疾病的差异作用。
Leukemia. 2024 Jun;38(6):1342-1352. doi: 10.1038/s41375-024-02219-5. Epub 2024 Mar 15.
8
Ex Vivo Expansion and Homing of Human Cord Blood Hematopoietic Stem Cells.人脐血造血干/祖细胞的体外扩增与归巢。
Adv Exp Med Biol. 2023;1442:85-104. doi: 10.1007/978-981-99-7471-9_6.
9
Deciphering the differential impact of thrombopoietin/MPL signaling on hematopoietic stem/progenitor cell function in bone marrow and spleen.解析促血小板生成素/MPL 信号对骨髓和脾脏造血干细胞/祖细胞功能的差异影响。
Stem Cell Reports. 2024 Feb 13;19(2):211-223. doi: 10.1016/j.stemcr.2023.12.004. Epub 2024 Jan 11.
10
Thrombopoietin-independent generation of platelet-like particles from megakaryoblastic cells.巨核细胞来源的血小板样颗粒的促血小板生成素非依赖性生成。
Sci Rep. 2023 Dec 18;13(1):22553. doi: 10.1038/s41598-023-50111-6.

本文引用的文献

1
Thrombopoietin in vitro and in vivo.体外和体内的血小板生成素
Cytokines Cell Mol Ther. 1998 Mar;4(1):25-34.
2
Murine hematopoietic stem cells committed to macrophage/dendritic cell formation: stimulation by Flk2-ligand with enhancement by regulators using the gp130 receptor chain.定向分化为巨噬细胞/树突状细胞的小鼠造血干细胞:Flk2配体的刺激以及使用gp130受体链的调节因子的增强作用
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11552-6. doi: 10.1073/pnas.94.21.11552.
3
Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin.早期作用细胞因子在单细胞水平直接促进具有多系分化潜能的人原始CD34+CD38-骨髓细胞存活并抑制其凋亡的能力:血小板生成素的关键作用
Blood. 1997 Sep 15;90(6):2282-92.
4
Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.重组人c-Mpl配体(血小板生成素)不仅在体外作用于巨核细胞祖细胞,还作用于红系祖细胞和多能祖细胞。
Exp Hematol. 1997 Sep;25(10):1025-33.
5
Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.通过联合聚乙二醇化重组人巨核细胞生长和发育因子与重组人粒细胞集落刺激因子,在骨髓抑制性化疗的非人灵长类动物模型中预防血小板减少症和中性粒细胞减少症。
Blood. 1997 Jan 1;89(1):155-65.
6
Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3.血小板生成素而非促红细胞生成素,与早期作用的细胞因子协同作用,直接刺激原始小鼠骨髓祖细胞的多谱系生长:与c-kit和FLT3配体的不同相互作用。
Blood. 1996 Dec 15;88(12):4481-92.
7
Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer.聚乙二醇化重组人巨核细胞生长和发育因子(PEG-rHuMGDF)对晚期癌症患者的促血小板生成作用。
Lancet. 1996 Nov 9;348(9037):1279-81. doi: 10.1016/S0140-6736(96)04471-6.
8
Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy-1+Lin- primitive progenitor cells.血小板生成素可刺激巨核细胞生成、骨髓生成,以及单个CD34⁺Thy-1⁺Lin⁻原始祖细胞来源的CD34⁺祖细胞的扩增。
Blood. 1996 Sep 1;88(5):1619-31.
9
Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice.血小板生成素可加速骨髓抑制小鼠的血小板、红细胞和中性粒细胞恢复。
Exp Hematol. 1996 Aug;24(10):1238-46.
10
Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice.血小板生成素和c-mpl基因缺陷小鼠中红系和髓系祖细胞水平较低。
Blood. 1996 Aug 1;88(3):803-8.